Brekelmans CT - Search Results

1

Breast cancer after a negative screen: follow-up of women participating in the DOM Screening Programme.

Brekelmans CT, Collette HJ, Collette C, Fracheboud J, de Waard F. Brekelmans CT, et al. Eur J Cancer. 1992;28A(4-5):893-5. doi: 10.1016/0959-8049(92)90144-q. Eur J Cancer. 1992. PMID: 1524918

2

The epidemiological profile of women with an interval cancer in the DOM screening programme.

Brekelmans CT, Peeters PH, Faber JA, Deurenberg JJ, Collette HJ. Brekelmans CT, et al. Breast Cancer Res Treat. 1994;30(3):223-32. doi: 10.1007/BF00665964. Breast Cancer Res Treat. 1994. PMID: 7981442

3

Survival in interval breast cancer in the DOM screening programme.

Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ. Brekelmans CT, et al. Eur J Cancer. 1995 Oct;31A(11):1830-5. doi: 10.1016/0959-8049(95)00324-c. Eur J Cancer. 1995. PMID: 8541108

4

Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

Brekelmans CT, Westers P, Faber JA, Peeters PH, Collette HJ. Brekelmans CT, et al. J Epidemiol Community Health. 1996 Feb;50(1):68-71. doi: 10.1136/jech.50.1.68. J Epidemiol Community Health. 1996. PMID: 8762357 Free PMC article.

5

Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups.

Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ. Brekelmans CT, et al. Cancer. 1996 Sep 15;78(6):1220-8. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1220::AID-CNCR8>3.0.CO;2-D. Cancer. 1996. PMID: 8826943

6

[Mass screening for breast cancer in women younger than 50; a literature review of the probable effect on mortality].

Collette HJ, Collette C, Brekelmans CT, de Waard F. Collette HJ, et al. Among authors: brekelmans ct. Ned Tijdschr Geneeskd. 1991 Sep 21;135(38):1766-7. Ned Tijdschr Geneeskd. 1991. PMID: 1922537 Dutch. No abstract available.

7

Hereditary breast cancer growth rates and its impact on screening policy.

Tilanus-Linthorst MM, Kriege M, Boetes C, Hop WC, Obdeijn IM, Oosterwijk JC, Peterse HL, Zonderland HM, Meijer S, Eggermont AM, de Koning HJ, Klijn JG, Brekelmans CT. Tilanus-Linthorst MM, et al. Among authors: brekelmans ct. Eur J Cancer. 2005 Jul;41(11):1610-7. doi: 10.1016/j.ejca.2005.02.034. Eur J Cancer. 2005. PMID: 15978801

8

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.

Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG; Dutch MRI Screening (MRISC) Study Group. Kriege M, et al. Among authors: brekelmans ct. Cancer. 2006 Jun 1;106(11):2318-26. doi: 10.1002/cncr.21863. Cancer. 2006. PMID: 16615112 Free article.

9

Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

Brekelmans CT, Voogd AC, Botke G, van Geel BN, Rodrigus P, Rutgers EJ, Klijn JG, Coebergh JW. Brekelmans CT, et al. Eur J Cancer. 1999 Apr;35(4):620-6. doi: 10.1016/s0959-8049(99)00008-8. Eur J Cancer. 1999. PMID: 10492637

10

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

Seynaeve C, Verhoog LC, van de Bosch LM, van Geel AN, Menke-Pluymers M, Meijers-Heijboer EJ, van den Ouweland AM, Wagner A, Creutzberg CL, Niermeijer MF, Klijn JG, Brekelmans CT. Seynaeve C, et al. Among authors: brekelmans ct. Eur J Cancer. 2004 May;40(8):1150-8. doi: 10.1016/j.ejca.2004.01.017. Eur J Cancer. 2004. PMID: 15110878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters